Alternative statutory remedy and unexplained delay barred writ review of customs confiscation adjudication, leaving merits for appellate consideration...
Authorised courier due diligence protects against penalties where declared exports conceal prohibited goods despite proper documentation and customs p...
Customs-controlled container movement now extends to DP World facilities, subject to segregation, inspections, reconciliation, and EXIM cargo priority...
Medicines and consumables supplied by a hospital pharmacy to in-patients during diagnosis or treatment are treated as part of a composite supply of healthcare services, not as separate retail sales. The Authority states that in-patient care includes the full bundle of medical, pharmaceutical, paramedical, nursing, laboratory and allied services from admission to discharge, and that such supplies are naturally bundled with the principal healthcare service in the ordinary course of business. Applying section 8(a), the composite supply assumes the character of healthcare services and is exempt under Entry 74 of Notification No. 12/2017-C.T. (Rate); the circular on in-patient healthcare was also relied on as supporting this treatment.
Medicines and consumables supplied by a hospital pharmacy to in-patients during diagnosis or treatment are treated as part of a composite supply of healthcare services, not as separate retail sales. The Authority states that in-patient care includes the full bundle of medical, pharmaceutical, paramedical, nursing, laboratory and allied services from admission to discharge, and that such supplies are naturally bundled with the principal healthcare service in the ordinary course of business. Applying section 8(a), the composite supply assumes the character of healthcare services and is exempt under Entry 74 of Notification No. 12/2017-C.T. (Rate); the circular on in-patient healthcare was also relied on as supporting this treatment.
Note: It is a system-generated summary and is for quick reference only.